This may also explain that the association of upregulation of RPS11 with poor prognosis is more pronounced in patients with newly diagnosed primary GBM, a GBM subtype that more often lacks p53 mutations than secondary GBM [57, 58]. Here, TP53 is linked to glioblastoma.